StonvexLoading…
StonvexStonvexStonvexCore line items from RNAC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $0.00 | $400.00K | $400.00K | $400.00K |
Operating Income | $-26.50M | $-143.41M | $-64.77M | $-43.70M |
Net Income | $-39.18M | $-130.30M | $-37.73M | $15.89M |
EPS (Diluted) | $-1.46 | $-5.02 | $-1.45 | $-0.07 |
Total Assets | $288.39M | $296.41M | $372.68M | $388.89M |
Total Liabilities | $436.51M | $422.65M | $408.52M | $391.42M |
Cash & Equivalents | $118.64M | $125.14M | $143.38M | $160.32M |
Free Cash Flow OCF − CapEx | $-22.16M | $-79.39M | $-61.19M | $-44.30M |
Shares Outstanding | 28.54M | 26.01M | 26.00M | 26.00M |